Osteopenia and osteoporosis in women with breast cancer

This publication has 116 references indexed in Scilit:

• Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
  Journal of Clinical Oncology, 2003
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• Raloxifene
  Drugs, 2000
• Bone Mineral Density and Risk of Breast Cancer: Differences by Family History of Breast Cancer
  American Journal of Epidemiology, 1998
• A Study of the Effects of Tamoxifen in the Frail Elderly: Difficulties Encountered in Nursing Home Research
  Women & Health, 1997
• Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up
  New England Journal of Medicine, 1995
• Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden)
  Cancer Causes & Control, 1994
• Breast cancer and osteoporosis—A bridge at last
  European Journal Of Cancer, 1993
• Effects of anti-estrogens on bone in castrated and intact female rats
  Breast Cancer Research and Treatment, 1987